Mitoconix Bio hits $20M series A for neurodegenerative R&D
by Ben Adams | Jun 27, 2017 Its tech is based around Stanford's work on mitochondrial function Preclinical startup Mitoconix Bio has secured a $20 million series A round for its research work on neurological disorders, including its lead candidate for Huntington’s disease. The round was led by Remiges Ventures with help from OrbiMed, [...]